Kalmar Investments’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
SGA
WP
Kalmar Investments's CLB Position: Q1 2017 in Review
Kalmar Investments sold out of Core Laboratories (CLB) in Q1 2017, closing a stake of 117,035 shares — an estimated $14M sold.
Kalmar Investments first reported a position in CLB in Q2 2013 and held it in 15 quarters. The position peaked at $65.4M in Q2 2013. 360 funds tracked by Wall St. Rank hold CLB as of Q1 2017.
- Kalmar Investments reported no remaining Core Laboratories position as of Q1 2017 after selling out during the quarter.
- Kalmar Investments sold 117,035 Core Laboratories shares in Q1 2017, an estimated $14M.
- Kalmar Investments first reported a position in Core Laboratories in Q2 2013 and held it in 15 quarters.
- Kalmar Investments's Core Laboratories position peaked at $65.4M in Q2 2013.
- 360 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2017.
Based on Kalmar Investments's 13F filing for Q1 2017, filed 26 Apr 2017.